The First EASL NAFLD Summit: Diagnosis and pharmacotherapy of NASH 2017 covers topics such as:
- Patient management
- NAFLD pathogenesis
- Non-invasive assessment of fibrosis
- Prognostic and therapeutic targets
- Biomarkers
- Apoptosis
- Hormonal and bile acids signalling
- Insulin resistance and signalling
- Inflammation and immunity in NASH
- Oxidative and mitochondrial stress
- Gut microbiota
- Carcinogenesis
The First EASL NAFLD Summit: Diagnosis and pharmacotherapy of NASH 2017 brings together:
- Clinical researchers
- Basic and translational scientists
- Hepatologists
- Industry / Biotechnology
- Regulatory and funding agencies
- Health professionals
- Young researchers and trainees
